Temozolomide-Resistant Glioma Cells Are Sensitive to Chloroethylating Nitrosourea Compounds in Combination with ATR Inhibitors

被引:0
|
作者
Jackson, C. [1 ]
Kalathil, A. N. [1 ]
Sundaram, R. K. [2 ]
Bindra, R. S. [1 ]
机构
[1] Yale Univ, New Haven, CT USA
[2] Yale Univ, Sch Med, New Haven, CT USA
关键词
D O I
10.1016/j.ijrobp.2019.06.1098
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3481
引用
收藏
页码:E639 / E639
页数:1
相关论文
共 50 条
  • [1] TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS
    Jackson, Christopher
    Kalathil, Aravind
    Bindra, Ranjit
    NEURO-ONCOLOGY, 2019, 21 : 94 - 94
  • [2] Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
    Ohba, Shigeo
    Yamashiro, Kei
    Hirose, Yuichi
    CANCERS, 2021, 13 (11)
  • [3] INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE
    Ohba, S.
    Hirose, Y.
    NEURO-ONCOLOGY, 2017, 19 : 63 - 64
  • [4] INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE
    Ohba, Shigeo
    Hirose, Yuichi
    NEURO-ONCOLOGY, 2017, 19 : 64 - 64
  • [5] Differential Characterization of Temozolomide-Resistant Human Glioma Cells
    Lai, Sheng-Wei
    Huang, Bor-Ren
    Liu, Yu-Shu
    Lin, Hsiao-Yun
    Chen, Chun-Chuan
    Tsai, Cheng-Fang
    Lu, Dah-Yuu
    Lin, Chingju
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [6] PARP INHIBITORS RESTORE TEMOZOLOMIDE SENSITIVITY IN MSH6-DEFICIENT TEMOZOLOMIDE-RESISTANT GLIOMA MODELS
    Higuchi, Fumi
    Wakimoto, Hiroaki
    Cahill, Daniel
    NEURO-ONCOLOGY, 2017, 19 : 67 - 67
  • [7] DEVELOPMENT OF ANTITUMOR COMPOUNDS FOR TEMOZOLOMIDE-RESISTANT TUMORS
    Lee, Sang Y.
    Slagle-Webb, Becky
    Rizk, Elias
    Miller, Patti
    Zhang, Xuesheng
    Ponnuru, Padma
    Sheehan, Jonas
    Connor, James R.
    NEURO-ONCOLOGY, 2009, 11 (05) : 595 - 595
  • [8] Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
    Ryu, Chung Heon
    Yoon, Wan Soo
    Park, Kwang Ywel
    Kim, Seong Muk
    Lim, Jung Yeon
    Woo, Ji Sun
    Jeong, Chang Hyun
    Hou, Yun
    Jeun, Sin-Soo
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
  • [9] The development of MAGMAS as a potential therapeutic target in temozolomide-resistant glioma
    Tran, Jennifer D.
    Lepe, Javier J.
    Kenney, Maria C.
    Das, Bhaskar C.
    Bota, Daniela A.
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
    Rocha, C. R. R.
    Garcia, C. C. M.
    Vieira, D. B.
    Quinet, A.
    de Andrade-Lima, L. C.
    Munford, V.
    Belizario, J. E.
    Menck, C. F. M.
    CELL DEATH & DISEASE, 2014, 5 : e1505 - e1505